AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease. (Q66546016)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease. |
clinical trial |
Statements
Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4076 Following Multiple Ascending Dose Administration to T2DM Subjects With Non-Alcoholic Fatty Liver Disease (English)
0 references
18 July 2016
0 references
28 December 2020
0 references
14
0 references
18 year
0 references
70 year
0 references